✦ LIBER ✦

Experience with Neoral versus Sandimmune in primary liver transplant recipients

✍ Scribed by C. W. Pinson; W. C. Chapman; J. K. Wright; E. B. Hunter; J. A. Awad; D. S. Raiford; J. L. Payne; S. Geevarghese; T. K. Blair; D. H. Van Buren

Publisher: Springer
Year: 1998
Tongue: English
Weight: 229 KB
Volume: 11
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s001470050479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of pharmacokinetics of neoral

Comparison of pharmacokinetics of neoral and sandimmune in stable pediatric liver transplant recipients

✍ van Mourik, Indra D. M. ;Thomson, Mike ;Kelly, Deirdre A. 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 79 KB

Cyclosporine (Sandimmune; Novartis Pharmaceuticals UK Ltd) is an effective immunosuppressive drug, but its lipid formulation and variable absorption may expose children to the risk of rejection during episodes of gastroenteritis after liver transplantation. Neoral (Novartis) is a microemulsified for

Single-center experience with tacrolimus

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

✍ J. M. M. Boots; Elly M. van Duijnhoven; Maarten H. L. Christiaans; Fred H. M. Ni 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 241 KB

A randomized, prospective, pharmacoecono

A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients

✍ Surendra Shenoy; Karen L. Hardinger; Jeffrey Crippin; Kevin Korenblat; Mauricio 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 1 views

Two-hour postdose cyclosporine (C2) monitoring is becoming an accepted method of therapeutic drug monitoring, although it is not known whether C2 monitoring is superior to tacrolimus (FK)-based immunosuppression. The purpose of this trial was to compare the safety, efficacy, and pharmacoeconomics of

Predictors and outcome of early- versus

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression

✍ N. Singh; T. Gayowski; M. M. Wagener; I. R. Marino 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 613 KB

Graft-versus-host disease in murine bone

Graft-versus-host disease in murine bone marrow transplantation. I. Modification of GVHD by preimmunization of recipients with spleen cells of primary recipients undergoing GVHD

✍ Reginald M. Gorczynski; Marion Kennedy; Maria Robillard 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 797 KB

A prospective cross-over study comparing

A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection

✍ Amany Zekry; Margret Gleeson; Seren Guney; Geoffrey W. McCaughan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

It has been suggested that Mycophenolate Mofetil (MMF) may have an antiviral effect in patients with recurrent HCV infection post-liver transplantation. We conducted a prospective cross-over study in liver transplant recipients with recurrent chronic HCV infection to examine whether substitution of